|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 471/04 | (2006.01) |
| A61K 31/551 | (2006.01) | ||
| A61P 1/04 | (2006.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/28 | (2006.01) |
| (11) | Number of the document | 2888259 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13783671.4 |
| Date of filing the European patent application | 2013-08-21 | |
| (97) | Date of publication of the European application | 2015-07-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-07 |
| (46) | Date of publication of the claims translation | 2018-06-11 |
| (86) | Number | PCT/IB2013/056782 |
| Date | 2013-08-21 |
| (87) | Number | WO 2014/030128 |
| Date | 2014-02-27 |
| (30) | Number | Date | Country code |
| 201215033 | 2012-08-23 | GB |
| (72) |
BEHNKE, Dirk, CH
CARCACHE, David, CH
ERTL, Peter, CH
KOLLER, Manuel, CH
ORAIN, David, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Diazepino dariniai, tinkami trapios X chromosomos sindromo, Parkinsono arba refliukso ligų gydymui |
| DIAZEPINONE DERIVATIVES USEFUL FOR THE TREATMENT OF FRAGILE X SYNDROME, PARKINSONS OR REFLUX DISEASE |
| Payment date | Validity (years) | Amount | |
| 2021-07-27 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2022-08-21 |